Abstract
IntroductionPeople with multiple sclerosis (pwMS) treated with ocrelizumab mount a T-cell response to vaccination, irrespective of humoral response. Correlates of this pattern of immune response remain unclear.MethodsPwMS on ocrelizumab who...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
